EEF1A2 and cancer: Since STn expressing cancers are associated with increased tumor initiation, progression and chemoresistance, it is reasonable to hypothesize that STn is also present on CSC populations, especially since protein CSC markers such as MUC1 and CD44v6 are known carriers of STn [9–12].